ATR - AptarGroup, Inc.
AptarGroup NYSE: ATR used its annual meeting to announce a planned chief executive transition, report that shareholders approved all items on the ballot and provide an update on 2025 performance and early 2026 results.
ATR tops Q1 earnings estimates on strong sales growth, but profit declines, pharma headwinds and margin pressure send shares down despite an upbeat Q2 outlook.
ITAD Firm, Advanced Technology Recycling (ATR), now offers wholesale electronics and computers to the general public through our online auction platform.
On May 01, 2026, AptarGroup Inc (ATR) shares fell 3.8% to a current price of $119.02. The stock has experienced significant volatility over the past year, with
AptarGroup, Inc. (ATR) Q1 2026 Earnings Call Transcript
AptarGroup (ATR) came out with quarterly earnings of $1.19 per share, beating the Zacks Consensus Estimate of $1.15 per share. This compares to earnings of $1.2 per share a year ago.
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports First Quarter 2026 Results.
AVY beats Q1 earnings estimates on strong volumes and cost control, with profits rising and cash flow swinging to positive despite mixed segment performance.
Graphic Packaging (GPK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Avery Dennison (AVY) came out with quarterly earnings of $2.47 per share, beating the Zacks Consensus Estimate of $2.41 per share. This compares to earnings of $2.3 per share a year ago.
Cwm LLC increased its position in shares of AptarGroup, Inc. (NYSE: ATR) by 102.5% during the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 10,781 shares of the industrial products company's stock after purchasing an additional 5,457 shares during the quarter. Cwm
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Declares Quarterly Dividend.
AptarGroup (ATR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AI-Designed Dual ATR-mTOR Inhibitor Demonstrates In Vivo Efficacy; Novel LNP Formulation of Bifunctional PARP/HDAC Inhibitor kt-3283 Successfully Characterized AI-Designed Dual ATR-mTOR Inhibitor Demonstrates In Vivo Efficacy; Novel LNP Formulation of Bifunctional PARP/HDAC Inhibitor kt-3283 Successfully Characterized
CINCINNATI, April 08, 2026 (GLOBE NEWSWIRE) -- Aptar Digital Health, a global leader in digital health solutions enhancing the patient experience, and Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® On-Body Delivery System, today announced a strategic partnership naming Aptar Digital Health as Enable's preferred digital health partner for the enFuse® system. This digital solution will be designed to guide patients and caregivers throughout the injection process and help strengthen engagement support before, during and after administration.
SG Americas Securities LLC lifted its stake in shares of AptarGroup, Inc. (NYSE: ATR) by 262.8% in the undefined quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 23,848 shares of the industrial products company's stock after buying an additional 17,274 shares during the quarter.
ATR, ABR and HVT have been added to the Zacks Rank #5 (Strong Sell) List on March 26, 2026.
ACCO, ATR and OBDC have been added to the Zacks Rank #5 (Strong Sell) List on March 20th, 2026.
ATR, BMI and BBSI have been added to the Zacks Rank #5 (Strong Sell) List on March 18, 2026.
CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Announces Gael Touya as its Next President and Chief Executive Officer; Stephan B. Tanda to Retire by the End of the Year.